CVS tops estimates, hikes guidance as insurance business shows some improvement
The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per share.
CVS
since
auto-detected in 59 stories
7 days ago
23 days ago
Shares of CVS and Dollar General made a turnaround due to their 'newfound sole survivor status,' Jim Cramer says
CNBC's Jim Cramer on Tuesday suggested why CVS and Dollar General have seen gains recently after lagging last year.
85 days ago
CVS shares are up 45% this year — here's why it may be starting to turn its business around
Some analysts are more optimistic about CVS' ability to navigate higher-than-expected medical costs in its insurance unit moving forward.
CVS shares are up 45% this year — here's why it may be starting to turn its business around
Some analysts are more optimistic about CVS' ability to navigate higher-than-expected medical costs in its insurance unit moving forward.
CVS gets an upgrade to buy from Leerink Partners after pharmacy operator's strong earnings
CVS Health has more room to run even as the broader health care segment remains troubled, according to Leerink Partners.
86 days ago
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled interest in cracking down on PBMs.
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled interest in cracking down on PBMs.
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
page 1 of 1